Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV004591567 | SCV005078556 | uncertain significance | not provided | 2023-09-15 | criteria provided, single submitter | clinical testing | Identified in a patient with Kallmann syndrome in published literature (Dai et al., 2020); In silico analysis supports that this missense variant does not alter protein structure/function; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (Richards et al., 2015); This variant is associated with the following publications: (PMID: 32060892, 36517585) |
OMIM | RCV001785417 | SCV002026472 | risk factor | Hypogonadotropic hypogonadism 16 with or without anosmia | 2021-11-22 | no assertion criteria provided | literature only | |
Prevention |
RCV004749740 | SCV005365729 | uncertain significance | SEMA3A-related disorder | 2024-03-15 | no assertion criteria provided | clinical testing | The SEMA3A c.1372G>A variant is predicted to result in the amino acid substitution p.Val458Ile. This variant has been reported in an individual with isolated hypogonadotropic hypogonadism; in addition, functional studies suggested that the p.Val458Ile change prevented extracellular secretion of SEMA3A protein (Dai et al. 2020. PubMed ID: 32060892). This variant is reported in 0.020% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |